Showing results (1-10 of 31) with videos related to
Sort By:
Pageof 4
Clinical Journal of the American Society of Nephrology : CJASN|September 19, 2007
Parvovirus B19 and the kidneyMeryl Waldman, Jeffrey B KoppNature Reviews. Nephrology|July 8, 2009
Controversies in the treatment of idiopathic membranous nephropathyMeryl Waldman, Howard A AustinNature Clinical Practice. Nephrology|September 27, 2007
Parvovirus-B19-associated complications in renal transplant recipientsMeryl Waldman, Jeffrey B KoppJournal of the American Society of Nephrology : JASN|August 4, 2012
Treatment of idiopathic membranous nephropathyMeryl Waldman, Howard A AustinJournal of Immunological Methods|February 8, 2017
Detection and monitoring PLA<sub>2</sub>R autoantibodies by LIPS in membranous nephropathyPeter D Burbelo, Laurence H Beck, Meryl WaldmanThe Journal of Biological Chemistry|January 22, 2022
Structural determinants of the dominant conformational epitopes of phospholipase A2 receptor in primary membranous nephropathyHong Tang, Richard Zhu, Meryl Waldman, et al.Seminars in Nephrology|November 18, 2008
Viruses and kidney disease: beyond HIVMeryl Waldman, Vickie Marshall, Denise Whitby, et al.Medrxiv : the Preprint Server for Health Sciences|October 4, 2023
The predictive and prognostic value of peripheral blood antigen-specific memory B cells in phospholipase A2 receptor-associated membranous nephropathyRichard Zhu, Hong Tang, Lilian Howard, et al.Journal of Clinical Apheresis|December 12, 2018
Treatment-resistant PLA2R-negative membranous nephropathy responsive to low-density lipoprotein apheresisJames M Szymanski, Meryl Waldman, Cathy Conry-Cantilena, et al.Journal of the American Society of Nephrology : JASN|September 11, 2014
Identification of the immunodominant epitope region in phospholipase A2 receptor-mediating autoantibody binding in idiopathic membranous nephropathyLiyo Kao, Vinson Lam, Meryl Waldman, et al.Pageof 4